Radiation in management of patients with dermatofibrosarcoma protuberans

被引:112
作者
Suit, H
Spiro, I
Mankin, HJ
Efird, J
Rosenberg, AE
机构
[1] HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT ORTHOPAED SURG,BOSTON,MA 02114
[2] HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02114
关键词
D O I
10.1200/JCO.1996.14.8.2365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The preferred treatment of dermatofibrosarcoma protuberans (DFSP) is wide resection, namely, margins greater than or equal to 3 cm beyond the evident disease and histologically negative margins. We assess the success achieved by radiation combined with surgery for positive/close margins or by radiation alone for those tumors that are not resectable For technical/medical reasons. The literature on this point is virtually nonexistent. Materials and Methods: The outcome of treatment of 18 patients with DFSP by radiation alone (n = 3) and radiation and surgery (n = 15) at the Massachusetts General Hospital was assessed. All of the lesions at the time of the treatment by radiation alone or combined with surgery were less than 10 cm. This was the maximum dimension. The actual tumor volume was much less than indicated by this maximum dimension, as the tumors were usually relatively flat. Results: The 10-year actuarial local control rate was determined to be 88%. Local control was realized in the three patients treated by radiation alone, with follow-up periods of greater than or equal to 9 years. Among 15 patients treated by radiation and surgery, there have been three local failures; the 10-year actuarial local control rate was 84%. The three local failures occurred in 12 patients whose surgical margins were positive. One of these three local failures developed in the group of two patients whose lesions were scored as grade II. Conclusion: Radiation in well-tolerated dose schedules is an effective option in the management of patients with DFSP. This appears to be true for radiation alone or postoperatively for margin-positive disease (primary or recurrent). (C) 1996 by American Society of Clinical Oncology.
引用
收藏
页码:2365 / 2369
页数:5
相关论文
共 14 条
[1]   CLONAL ORIGIN OF DERMATOFIBROSARCOMA PROTUBERANS [J].
ALLAN, AE ;
TSOU, HC ;
HARRINGTON, A ;
STASKO, T ;
LEE, XH ;
SI, SP ;
GRANDE, DJ ;
PEACOCKE, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (02) :99-102
[2]   DERMATOFIBROSARCOMA PROTUBERANS - A CLINICOPATHOLOGICAL STUDY OF 19 CASES AND REVIEW OF WORLD LITERATURE [J].
BENDIXHANSEN, K ;
MYHREJENSEN, O ;
KAAE, S .
SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 1983, 17 (03) :247-252
[3]   DERMATOFIBROSARCOMA PROTUBERANS - A CLINICOPATHOLOGICAL REVIEW WITH EMPHASIS ON FIBROSARCOMATOUS AREAS [J].
CONNELLY, JH ;
EVANS, HL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (10) :921-925
[4]  
Enzinger FM, 1988, SOFT TISSUE TUMORS, P252
[5]  
GASKILL HV, 1993, SOFT TISSUE SARCOMAS, P101
[6]  
GOLDBLUM JR, 1995, ARCH PATHOL LAB MED, V119, P238
[7]   IMMUNOHISTOCHEMICAL MARGIN CONTROL APPLIED TO MOHS MICROGRAPHIC SURGICAL EXCISION OF DERMATOFIBROSARCOMA PROTUBERANS [J].
JIMENEZ, FJ ;
GRICHNIK, JM ;
BUCHANAN, MD ;
CLARK, RE .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1994, 20 (10) :687-689
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]  
MARK RJ, 1993, ARCH OTOLARYNGOL, V119, P891
[10]  
OSULLIVAN B, 1995, INT J RAD ONCOL BI S, V1, P289